Shares of Emcure Pharma surges over 31 percent in debut trade
New Delhi: Shares of Emcure Pharmaceuticals Ltd made a debut on Wednesday as they listed with a significant premium of over 31 percent against their issue price of Rs 1,008.
The stock opened trading at Rs 1,325.05, up 31.45 per cent on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), marking a strong initial surge.
Later, the company's stock zoomed 37.30 per cent to Rs 1,384 on BSE and 37.40 per cent to Rs 1,385 on NSE.
According to PTI report, the company's market valuation stood at Rs 25,546.24 crore.
The initial public offering (IPO) of Bain Capital-backed Emcure Pharmaceuticals received 67.87 times subscription on the final day of the offer on Friday amid encouraging participation from institutional buyers.
The initial share sale had a price band of Rs 960-1,008 per share.
The IPO had a fresh issuance of equity shares worth Rs 800 crore and an offer of sale (OFS) of 1.14 crore shares worth Rs 1,152 crore at the upper end of the price band by promoters and existing shareholders.
This aggregated the total issue size to Rs 1,952 crore.
The Pune-based company is engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
Read also: Emcure Pharma set to launch IPO on July 3
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd